Growth Metrics

Thermo Fisher Scientific (TMO) Total Non-Current Liabilities (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Total Non-Current Liabilities readings, the most recent being $56.9 billion for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 24.53% to $56.9 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $56.9 billion, a 24.53% increase, with the full-year FY2025 number at $52.7 billion, up 20.29% from a year prior.
  • Total Non-Current Liabilities hit $56.9 billion in Q1 2026 for Thermo Fisher Scientific, up from $52.7 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $56.9 billion in Q1 2026 to a low of $42.5 billion in Q4 2022.
  • Median Total Non-Current Liabilities over the past 5 years was $47.0 billion (2024), compared with a mean of $47.4 billion.
  • Biggest five-year swings in Total Non-Current Liabilities: surged 71.08% in 2022 and later fell 7.56% in 2024.
  • Thermo Fisher Scientific's Total Non-Current Liabilities stood at $48.9 billion in 2022, then fell by 3.12% to $47.4 billion in 2023, then fell by 7.56% to $43.8 billion in 2024, then increased by 20.29% to $52.7 billion in 2025, then rose by 8.09% to $56.9 billion in 2026.
  • The last three reported values for Total Non-Current Liabilities were $56.9 billion (Q1 2026), $52.7 billion (Q4 2025), and $47.7 billion (Q3 2025) per Business Quant data.